General Archive
-
Protein and Antibody Engineering Summit Europe
About the event The Protein & Antibody Engineering Summit is the largest European event covering all aspects of protein and…
-
USAMRIID: A transatlantic collaboration to develop a treatment for Crimean-Congo hemorrhagic fever
USAMRIID: A transatlantic collaboration to develop a treatment for Crimean-Congo hemorrhagic fever We have joined forces with the U.S. Army…
-
News releasesLifeArc and Cleveland Clinic join forces to develop new monoclonal antibody therapeutics for patients with high unmet medical needs
LifeArc and Cleveland Clinic, a nonprofit, multispecialty academic medical centre, have signed a new 10-year Master Services Agreement (MSA) for…
-
LifeArc antibody showcase at Babraham Research Campus
About the showcase We are hosting a roadshow to showcase the capabilities of our newly launched antibody discovery platform, B-SMART™,…
-
Protein and Antibody Engineering Europe Summit
About the event The Protein and Antibody Engineering Europe Summit is the largest protein and antibody engineering event in Europe,…
-
News releasesTwo major UK decisions announced on use of Alzheimer’s drug, lecanemab
Today, two major decisions have been made on lecanemab (Leqembi®) – the Alzheimer’s drug that we helped humanise, which slows the…
-
ArticlesStudy reveals potential new way to treat colorectal cancer
Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.
-
LifeArc scientists play pivotal role in the search for a COVID-19 antibody therapy
While much attention in the race for treatments for Covid-19 has been on the development of new vaccines, scientists have…
-
Keytruda: a new generation of cancer treatment
In 2007, LifeArc entered a collaboration with Organon – ultimately acquired by Merck – to translate innovative drug targets into…
-
News releases
TYSABRI gains market approval
Biogen Idec and Elan Corporation yesterday announced the approval of a supplemental Biologics License Application (sBLA) by the U.S. Food…
-
News releasesTherapeutic Antibody Group starts
The Therapeutic Antibody Group (TAG) will comprise former AERES scientists. As part of MRCT’s evolving strategy of adding significant value…